305 related articles for article (PubMed ID: 16379614)
1. Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler.
Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
J Aerosol Med; 2005; 18(4):379-85. PubMed ID: 16379614
[TBL] [Abstract][Full Text] [Related]
2. A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times.
Leach CL; Colice GL
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):355-61. PubMed ID: 20575669
[TBL] [Abstract][Full Text] [Related]
3. Inhaled corticosteroid delivery systems: clinical role of a breath-actuated device.
Donnell D
Eur Rev Med Pharmacol Sci; 2001; 5(1):7-16. PubMed ID: 11860222
[TBL] [Abstract][Full Text] [Related]
4. Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans.
Leach C
J Allergy Clin Immunol; 1999 Dec; 104(6):S250-2. PubMed ID: 10588985
[TBL] [Abstract][Full Text] [Related]
5. Respiratory Tract Deposition of HFA-Beclomethasone and HFA-Fluticasone in Asthmatic Patients.
Leach CL; Kuehl PJ; Chand R; McDonald JD
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):127-33. PubMed ID: 26061801
[TBL] [Abstract][Full Text] [Related]
6. Targeting inhaled steroids.
Leach C
Int J Clin Pract Suppl; 1998 Sep; 96():23-7. PubMed ID: 10344030
[TBL] [Abstract][Full Text] [Related]
7. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers.
Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
Chest; 2002 Aug; 122(2):510-6. PubMed ID: 12171824
[TBL] [Abstract][Full Text] [Related]
8. Beclomethasone relative availability of oral versus inhaled beclomethasone dipropionate from an HFA-134A metered dose inhaler.
Soria I; Harrison LI; Machacek JH; Cline AC; Stampone PA
Biopharm Drug Dispos; 1998 Jul; 19(5):297-302. PubMed ID: 9673781
[TBL] [Abstract][Full Text] [Related]
9. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics.
Seale JP; Harrison LI
Respir Med; 1998 Jun; 92 Suppl A():9-15. PubMed ID: 9850358
[TBL] [Abstract][Full Text] [Related]
10. Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler.
Biswas R; Hanania NA; Sabharwal A
J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):256-266. PubMed ID: 28157430
[TBL] [Abstract][Full Text] [Related]
11. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone.
Leach CL; Davidson PJ; Boudreau RJ
Eur Respir J; 1998 Dec; 12(6):1346-53. PubMed ID: 9877489
[TBL] [Abstract][Full Text] [Related]
12. Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients.
De Backer W; Devolder A; Poli G; Acerbi D; Monno R; Herpich C; Sommerer K; Meyer T; Mariotti F
J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):137-48. PubMed ID: 20109122
[TBL] [Abstract][Full Text] [Related]
13. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
[TBL] [Abstract][Full Text] [Related]
14. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
[TBL] [Abstract][Full Text] [Related]
15. Influence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionate in children.
Agertoft L; Laulund LW; Harrison LI; Pedersen S
Pediatr Pulmonol; 2003 Mar; 35(3):192-9. PubMed ID: 12567387
[TBL] [Abstract][Full Text] [Related]
16. Effects of Formulation Variables on Lung Dosimetry of Albuterol Sulfate Suspension and Beclomethasone Dipropionate Solution Metered Dose Inhalers.
Schroeter JD; Sheth P; Hickey AJ; Asgharian B; Price OT; Holt JT; Conti DS; Saluja B
AAPS PharmSciTech; 2018 Jul; 19(5):2335-2345. PubMed ID: 29858973
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.
Vanden Burgt JA; Busse WW; Martin RJ; Szefler SJ; Donnell D
J Allergy Clin Immunol; 2000 Dec; 106(6):1209-26. PubMed ID: 11112914
[TBL] [Abstract][Full Text] [Related]
18. Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model.
Janssens HM; De Jongste JC; Hop WC; Tiddens HA
Chest; 2003 Jun; 123(6):2083-8. PubMed ID: 12796192
[TBL] [Abstract][Full Text] [Related]
19. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[TBL] [Abstract][Full Text] [Related]
20. HFA-BDP Metered-Dose Inhaler Exhaled Through the Nose Improves Eosinophilic Chronic Rhinosinusitis With Bronchial Asthma: A Blinded, Placebo-Controlled Study.
Kobayashi Y; Yasuba H; Asako M; Yamamoto T; Takano H; Tomoda K; Kanda A; Iwai H
Front Immunol; 2018; 9():2192. PubMed ID: 30337921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
